Literature DB >> 11673488

Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells.

S Somersan1, M Larsson, J F Fonteneau, S Basu, P Srivastava, N Bhardwaj.   

Abstract

Upon exposure to lysates or supernatants of necrotic transformed cell lines, human dendritic cells (DCs) undergo maturation. In contrast, DCs exposed to apoptotic transformed cell lines or necrotic lysates of primary cells remain immature. Analysis of supernatants of necrotic transformed cell lines showed them to be enriched in the heat shock proteins (hsp)70 and gp96, in contrast to supernatants of primary cells. Likewise, cells from a variety of primary human tumors contained considerably higher levels of hsp than their normal autologous tissue counterparts. Of the majority of human tumors enriched in hsps (hsp70 and/or gp96), their corresponding lysates matured DCs. The maturation effect of tumor cell lysates was abrogated by treatment with boiling, proteinase K, and geldanamycin, an inhibitor of hsps, suggesting that hsps rather than endotoxin or DNA were the responsible factors. Supporting this idea, highly purified, endotoxin-depleted hsp70, induced DC maturation similar to that seen with standard maturation stimuli LPS and monocyte conditioned medium. These results suggest that the maturation activity inherent within tumor cells and lines is mediated at least in part by hsps. The release of hsps in vivo as a result of cell injury should promote immunity through the maturation of resident DCs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673488     DOI: 10.4049/jimmunol.167.9.4844

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

1.  Autologous apoptotic T cells interact with dendritic cells, but do not affect their surface phenotype or their ability to induce recall immune responses.

Authors:  P J Newton; I V D Weller; D R Katz; B M Chain
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

2.  Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function.

Authors:  Amy D H Doody; Joseph T Kovalchin; Marianne A Mihalyo; Adam T Hagymasi; Charles G Drake; Adam J Adler
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

3.  Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines.

Authors:  Wolfgang W Leitner; Leroy N Hwang; Elke S Bergmann-Leitner; Steven E Finkelstein; Stephan Frank; Nicholas P Restifo
Journal:  Vaccine       Date:  2004-03-29       Impact factor: 3.641

Review 4.  Natural endogenous adjuvants.

Authors:  Kenneth L Rock; Arron Hearn; Chun-Jen Chen; Yan Shi
Journal:  Springer Semin Immunopathol       Date:  2004-10-14

Review 5.  Heat shock proteins: linking danger and pathogen recognition.

Authors:  Anke Osterloh; Minka Breloer
Journal:  Med Microbiol Immunol       Date:  2007-07-19       Impact factor: 3.402

6.  Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy.

Authors:  Paul Hatfield; Alison E Merrick; Emma West; Dearbhaile O'Donnell; Peter Selby; Richard Vile; Alan A Melcher
Journal:  J Immunother       Date:  2008-09       Impact factor: 4.456

7.  Targeting hepatitis B virus antigens to dendritic cells by heat shock protein to improve DNA vaccine potency.

Authors:  Qin-Long Gu; Xue Huang; Wen-Hong Ren; Lei Shen; Bing-Ya Liu; Si-Yi Chen
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

8.  Peptidases released by necrotic cells control CD8+ T cell cross-priming.

Authors:  Jaba Gamrekelashvili; Tamar Kapanadze; Miaojun Han; Josef Wissing; Chi Ma; Lothar Jaensch; Michael P Manns; Todd Armstrong; Elizabeth Jaffee; Ayla O White; Deborah E Citrin; Firouzeh Korangy; Tim F Greten
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

9.  Differential responses of cord and adult blood-derived dendritic cells to dying cells.

Authors:  On Hang Wong; Fang-Ping Huang; Alan K S Chiang
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

Review 10.  Hyperthermia as an immunotherapy strategy for cancer.

Authors:  Joseph J Skitzki; Elizabeth A Repasky; Sharon S Evans
Journal:  Curr Opin Investig Drugs       Date:  2009-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.